Call for Abstracts opens |
April 15, 2018 |
Online registration opens |
April 15, 2018 |
Abstract submission deadline EXTENDED |
Extended to July 30, 2018 |
Notice of Abstract adjudication |
August 9, 2018 |
Deadline for presenting authors to register |
August 31, 2018 |
Early registration deadline |
August 31, 2018 |
Please indicate your preference for oral or poster presentation in the online submission. Due to the limited number of oral presentations available in the SHSA program, meritorious abstracts not assigned to oral presentation, will be accepted for posters. Please indicate in the online submission system if you do not wish to accept a poster presentation in this instance.
An acknowledgement of your abstract submission(s) will be sent via email.
Abstracts will be peer reviewed, following the submission deadline on Monday, July 30, 2018. Notifications will be sent to the accepted abstract submitters by Thursday, August 9, 2018. Correspondence will be directed to the submitting author.
Topics
Please submit your abstract by selecting one category out of the following that best describes its scientific content. Categories will be used for reviewing and indexing purposes.
Disclosure of Conflict
Authors are required to complete a Disclosure of Conflict form as part of the abstract submission. These will be included in the Final Program. Abstracts must be free of commercial bias and should only identify drug products by their generic names.
Condition of Acceptance
A condition of acceptance is that you must register for the conference. Conference registration must be received by Friday, August 31 in order for the abstract to be included in the program.
Abstracts selected for presentation at the Symposium on Hidradenitis Suppurativa Advances will be reproduced exactly as submitted in the Final Program and substitutions will not be permitted. Please proofread your abstract before submitting.
An acknowledgement of your abstract submission(s) will be sent via email.
Abstracts will be peer reviewed, following the submission deadline on Monday, July 30, 2018. Notifications will be sent to the accepted abstract submitters by Thursday, August 9, 2018. Correspondence will be directed to the submitting author.
Topics
Please submit your abstract by selecting one category out of the following that best describes its scientific content. Categories will be used for reviewing and indexing purposes.
- Epidemiology
- QOL and disease burden
- Comorbidities
- Clinical presentations and disease severity
- Pathophysiology and basic science
- Treatment modalities
- Surgical treatments
Disclosure of Conflict
Authors are required to complete a Disclosure of Conflict form as part of the abstract submission. These will be included in the Final Program. Abstracts must be free of commercial bias and should only identify drug products by their generic names.
Condition of Acceptance
A condition of acceptance is that you must register for the conference. Conference registration must be received by Friday, August 31 in order for the abstract to be included in the program.
Abstracts selected for presentation at the Symposium on Hidradenitis Suppurativa Advances will be reproduced exactly as submitted in the Final Program and substitutions will not be permitted. Please proofread your abstract before submitting.
Abstract Submission Process
Abstracts submissions will be accepted via the online submission system only by clicking on the "Online Submission" above. Abstracts sent by email or mail will not be accepted.
All abstracts submitted must select from one of the conference topics for inclusion in the program. Abstracts should present new information, and not have been submitted or published elsewhere (at the time of submission). When submitting an abstract, please select the topic that best applies to your abstract. Topics can be selected from the drop-down menu of the online submission system.
Submitting authors and/or presenters may modify their submission(s) until the closing date of July 30, 2018 at 5:00pm PST.
Abstracts selected for poster or oral presentations in the 3rd Annual Symposium on HS Advances will be reproduced exactly as submitted and substitutions will not be permitted. Be sure to proofread your abstract very carefully before submitting. All accepted abstracts will be published in the Journal of Experimental Dermatology as a proceeding report with your name.
Abstract Guidelines
Abstracts submissions will be accepted via the online submission system only by clicking on the "Online Submission" above. Abstracts sent by email or mail will not be accepted.
All abstracts submitted must select from one of the conference topics for inclusion in the program. Abstracts should present new information, and not have been submitted or published elsewhere (at the time of submission). When submitting an abstract, please select the topic that best applies to your abstract. Topics can be selected from the drop-down menu of the online submission system.
Submitting authors and/or presenters may modify their submission(s) until the closing date of July 30, 2018 at 5:00pm PST.
Abstracts selected for poster or oral presentations in the 3rd Annual Symposium on HS Advances will be reproduced exactly as submitted and substitutions will not be permitted. Be sure to proofread your abstract very carefully before submitting. All accepted abstracts will be published in the Journal of Experimental Dermatology as a proceeding report with your name.
Abstract Guidelines
- Prepare your abstract in MS Word
- Do not use presentation software, such as PowerPoint
- Limit your abstract (body) to no more than 300 words
- It is suggested, other than case presentations, to separate your abstract into three (3) paragraphs:
- Introduction
- Methods, Results
- Conclusions
- Include learning objectives and a takeaway message.